Connection

Marek Jutel to Europe

Back to Details
This is a "connection" page, showing publications Marek Jutel has written about Europe.
Marek Jutel
Connection Strength
0.070
Europe
  1. Considerations on biologicals for patients with allergic disease in times of the COVID-19 pandemic: An EAACI statement. Allergy. 2020 11; 75(11):2764-2774.
    View in: PubMed
    Score: 0.016
  2. Emerging concepts and challenges in implementing the exposome paradigm in allergic diseases and asthma: a Practall document. Allergy. 2019 03; 74(3):449-463.
    View in: PubMed
    Score: 0.014
  3. Benefit of Bet v 1 contiguous overlapping peptide immunotherapy persists during first follow-up season. J Allergy Clin Immunol. 2018 08; 142(2):678-680.e7.
    View in: PubMed
    Score: 0.014
  4. Allergen manufacturing and quality aspects for allergen immunotherapy in Europe and the United States: An analysis from the EAACI AIT Guidelines Project. Allergy. 2018 04; 73(4):816-826.
    View in: PubMed
    Score: 0.013
  5. Challenges in the implementation of EAACI guidelines on allergen immunotherapy: A global perspective on the regulation of allergen products. Allergy. 2018 Jan; 73(1):64-76.
    View in: PubMed
    Score: 0.013
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.